Advertisement
Mankekar Family
Healthcare
19 March, 2021
TPG Growth leads Series C funding in Strides' biopharma division
Stelis Biopharma, a division of Mumbai-listed Strides Pharma Science, has raised $125 million (Rs 907 crore) as part of its ......